Brainsway is engaged in the research, development and marketing of a medical system for non-invasive treatment of common brain disorders. The medical system developed and manufactured by the company is based on a unique and breakthrough technology called Deep TMS, which can reach deeply and broadly into the brain and produce nerve stimulation or suppression. In the US, Brainsway is currently FDA cleared for the treatment of Major Depressive Disorder only, and has reimbursement by insurers, including both commercial and government payors, covering about 90% of the US population. The Company's systems are sold worldwide as well, with CE mark for a variety of indications.